Owens & Minor (OMI) Scheduled to Post Quarterly Earnings on Friday

Owens & Minor (NYSE:OMI) is scheduled to be posting its quarterly earnings results before the market opens on Friday, May 3rd. Analysts expect Owens & Minor to post earnings of $0.17 per share for the quarter. Owens & Minor has set its FY 2024 guidance at 1.400-1.700 EPS and its FY24 guidance at $1.40-$1.70 EPS.Individual that are interested in registering for the company’s earnings conference call can do so using this link.

Owens & Minor (NYSE:OMI) last posted its quarterly earnings data on Tuesday, February 20th. The company reported $0.69 earnings per share for the quarter, topping the consensus estimate of $0.66 by $0.03. The company had revenue of $2.66 billion for the quarter, compared to analysts’ expectations of $2.67 billion. Owens & Minor had a negative net margin of 0.40% and a positive return on equity of 11.62%. Owens & Minor’s revenue for the quarter was up 4.1% compared to the same quarter last year. During the same period in the prior year, the business earned $0.28 earnings per share. On average, analysts expect Owens & Minor to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Owens & Minor Trading Down 3.1 %

OMI stock opened at $23.98 on Thursday. The company has a market capitalization of $1.84 billion, a PE ratio of -44.46, a price-to-earnings-growth ratio of 0.80 and a beta of 0.43. Owens & Minor has a one year low of $13.34 and a one year high of $28.35. The company’s 50 day moving average price is $25.39 and its two-hundred day moving average price is $21.33. The company has a debt-to-equity ratio of 2.05, a quick ratio of 0.52 and a current ratio of 1.11.

Insider Buying and Selling

In related news, SVP Michael Wayne Lowry sold 10,000 shares of the company’s stock in a transaction dated Tuesday, February 27th. The shares were sold at an average price of $25.00, for a total value of $250,000.00. Following the transaction, the senior vice president now owns 71,654 shares in the company, valued at approximately $1,791,350. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, SVP Jonathan A. Leon sold 5,000 shares of the company’s stock in a transaction dated Monday, April 22nd. The shares were sold at an average price of $24.84, for a total transaction of $124,200.00. Following the completion of the sale, the senior vice president now owns 84,673 shares of the company’s stock, valued at approximately $2,103,277.32. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Michael Wayne Lowry sold 10,000 shares of the company’s stock in a transaction dated Tuesday, February 27th. The shares were sold at an average price of $25.00, for a total transaction of $250,000.00. Following the sale, the senior vice president now directly owns 71,654 shares of the company’s stock, valued at approximately $1,791,350. The disclosure for this sale can be found here. 2.62% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the stock. StockNews.com raised shares of Owens & Minor from a “hold” rating to a “buy” rating in a research note on Wednesday, February 21st. UBS Group cut their price target on shares of Owens & Minor from $28.00 to $26.00 and set a “buy” rating on the stock in a report on Monday, January 29th. Robert W. Baird lifted their price target on shares of Owens & Minor from $24.00 to $28.00 and gave the company a “neutral” rating in a report on Wednesday, April 10th. Leerink Partnrs restated a “market perform” rating on shares of Owens & Minor in a report on Monday, February 26th. Finally, TheStreet upgraded shares of Owens & Minor from a “d+” rating to a “c-” rating in a report on Monday, March 4th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, Owens & Minor presently has an average rating of “Hold” and a consensus target price of $23.86.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.